Secondary syphilitic lesions

Clinical Microbiology Reviews

Volumn 18, Issue 1, 2005, Pages 205-216

  Baughn, Robert E ^a,b   Musher, Daniel M ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; CEFTRIAXONE; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; TETRACYCLINE;

BACTERIAL VIRULENCE; BISEXUALITY; DISEASE COURSE; FEVER; HISTOPATHOLOGY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LABORATORY TEST; MALAISE; NONHUMAN; REAGIN TEST; REVIEW; SECONDARY SYPHILIS; SEX DIFFERENCE; SKIN DEFECT; SKIN MANIFESTATION; SPIROCHETE; TREPONEMA PALLIDUM; UNITED STATES;

CHRONIC DISEASE; HUMANS; MALE; SYPHILIS, CUTANEOUS; TREPONEMA PALLIDUM;

EID: 12844268081     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.18.1.205-216.2005     Document Type: Review

References (86)

1. Bayne, L. L., J. W. Schmidley, and D. S. Goodin. 1986. Acute syphilitic meningitis. Its occurrence after clinical and serologic cure of secondary syphilis with penicillin G. Arch. Neurol. 43:137-138.
2. Bauer, T. J., E. V. Price, and J. C. Cutler. 1952. Spinal fluid examinations among patients with primary or secondary syphilis. Am. J. Syph. 36:309.
3. Baughn, R. E., M. C. McNeeley, J. L. Jorizzo, and D. M. Musher. 1986. Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis. J. Immunol. 136: 1406-1414.
4. Baughn, R. E., and R. F. Schell. 2001. Immune responses to Treponema pallidum and Borrelia burgdorefi, p. 27.1-27.7. In R. R. Rich (ed.), Principles and practice of clinical immunology, 2nd ed. Mosby, St. Louis, Mo.
5. Berry, C. D., T. M. Hooton, A. C. Collier, and S. A. Lukehart. 1987. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N. Engl. J. Med. 6:1587-1589.
6. Bronzan, R., L. Echavarria, J. Hermida, M. Trepka, T. Burns, and K. Fox. 2002. Syphilis among men who have sex with men (MSM) in Miami-Dade County, Florida. Program Abstr. 2002 Nat. STD Prev. Conf., abstr. P135.
7. Carnauba, D., Jr., A. Bittencourt, and C. Brites. 2003. Atypical presentation of syphilis in an HTLV-1 infected patient. Braz. J. Infect. Dis. 7:273-277.
8. Centers for Disease Control and Prevention. 1995. Morb. Mortal. Wkly. Rep. 44:75.
9. Centers for Disease Control and Prevention. 1998. Primary and secondary syphilis-United States, 1997. Mob. Mortal. Wkly. Rep. 47:493-497.
10. Centers for Disease Control and Prevention. 1999. Resurgent bacterial sexually transmitted disease among men who have sex with men-King County, Washington, 1997-1999. Morb. Mortal. Wkly. Rep. 48:773-777.
11. Center for Disease Control and Prevention. 2001. Outbreak of syphilis among men who have sex with men-Southern California, 2000. Morb. Mortal. Wkly. Rep. 50:117-120.
12. Centers for Disease Control and Prevention. 2002. Primary and secondary syphilis among men who have sex with men-New York City, 2001. Morb. Mortal. Wkly. Rep. 51:853-856.
13. Centers for Disease Control and Prevention. 1999. The national plan to eliminate syphilis from the United States. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Atlanta, Ga.
14. Chapel, T. A. 1978. The variability of syphilitic chancres. Sex. Transm. Dis. 5: 68-70.
15. Chapel, T. A. 1980. The signs and symptoms of secondary syphilis. Sex. Transm. Dis. 7:161-164.
16. Chesson, H. W., T. S. Dee, and S. O. Aral. 2003 AIDS mortality may have contributed to the decline in syphilis in the United States in the 1990s. Sex. Transm. Dis. 30:419-424.
17. Clark, E. G., and N. Danbolt. 1964. The Oslo study of the natural course of untreated syphilis: an epidemiologic investigation based on a re-study of the Boeck-Bruusgaard material. Med. Clin. North Am. 48:613-621.
18. Collart, P., L.-J. Borel, and P. Durel. 1964. Significance of spiral organisms found, after treatment, in late human and experimental syphilis. Br. J. Vener. Dis. 40:81-89.
19. Danehower, W. F. 1964. Penicillin fallout and infectious syphilis. Med. Clin. North Am. 48:747-753.
20. Dennis, C. C. 1962. A history of syphilis. Charles C Thomas, Springfield, Ill.
21. Don, P. C., R. Rubinstein, and S. Christie. 1995. Malignant syphilis (lues maligna) and concurrent infection with HIV. Int. J. Dermatol. 34:403-407.
22. Dowell, M. E., P. G. Ross, D. M. Musher, T. R. Cate, and R. E. Baughn. 1992. Response of latent syphilis or neurosyphilis to ceftriaxone in persons infected with human immunodeficiency virus. Am. J. Med. 93:481-488.
23. Drusin, L. M., C. Singer, A. J. Valenti, and D. Armstrong. 1977. Infectious syphilis mimicking neoplastic disease. Arch. Intern. Med. 137:156-160.
24. Edlin, B. R., K. L. Irwin, D. D. Ludwig, et al. 1992. High-risk sex behavior among young street-recruited crack cocaine smokers in three American cities: an interim report. J. Psychoactive Drugs 23:363-371.
25. Engel, S., and W. Diezel. 1980. Persistent serum immune complexes in syphilis. Br. J. Vener. Dis. 56:221-222.
26. Falck, R. S., J. Wang, R. G. Carlson, and H. A. Siegal. 1997. Factors influencing condom use among heterosexual users of infection drugs and crack cocaine. Sex. Transm. Dis. 24:204-210.
27. Fiumara, N. J. 1980. Treatment of primary and secondary syphilis. Serological response. JAMA 243:2500-2502.
28. Folk, J. C., T. A. Weingeist, J. J. Corbett, L. A. Lobes, and R. C. Watzke. 1983. Syphilitic neuroretinitis. Am. J. Ophthalmol. 95:480-486.
29. Fracastoro, H. 1930. De contagione et contagiosis morbis et eorum curatione, libri III. Translated by W. C. Wright, G. P. Putnam's Sons, New York, NY.
30. Frederick, W. R., R. Delapenha, S. Barnes, et al. 1988. Secondary syphilis and HIV infection. Program. Abstr. 28th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 1175, p. 320.
31. Goh, B. T., G. W. Smith, L. Samarasinghe, V. Singh, and K. S. Lim. 1984. Penicillin concentrations in serum and cerebrospinal fluid after intramuscular injection of aqueous procaine penicillin 0.6 MU with and without probenecid. Br. J. Vener. Dis. 60:371-373.
32. Goodman, H. 1943. Notable contributions to the knowledge of syphilis. Froben Press, New York, N.Y.
33. Gorbach, P. M., S. O. Aral, C. Celum, et al. 2000. To notify or not to notify: STD patients' perspectives of partner notification in Seattle. Sex. Transm. Dis. 27:193-200.
34. 33a. Gorbach, S. L., J. G. Bartlett, and N. R. Blacklow (ed.). 2003. Infectious diseases, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
35. Gordon, S. M., M. E. Eaton, R. George, et al. 1994. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N. Engl. J. Med. 331:1469-1473.
36. Gourevitch, M. N., P. A. Selwyn, K. Davenny, et al. 1993. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann. Intern. Med. 118:350-355.
37. Harris, R. L., P. A. Rutecki, D. T. Donovan, M.-W. Bradshaw, and T. W. Williams, Jr. 1985. Fever, headache and hearing loss in a young homosexual man. Hosp. Pract. 20:167-170.
38. Held, J. L., M. Ross, V. Beltrani, Jr., S. R. Kohn, and M. E. Grossman. 1990. Noduloulcerative or "malignant" syphilis in an otherwise healthy woman: report and review of a dramatic dermatosis. Cutis 45:119-122.
39. Hicks, C. B., P. M. Benson, G. P. Lupton, and E. C. Tramont. 1987. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. Ann. Intern. Med. 107:492-495.
40. Hoff, H., and J. A. Shaby. 1940. Nervous manifestations of bejel. Trans. Ro. Soc. Trop. Med. Hyg. 33:549-551.
41. Holcombe, R. C. 1938. The holy wood and the Haitian myth of the origin of syphilis, p. 12-19. In Syphilis. Publication 6. American Association for the Advancement of Science, Washington, D.C.
42. Holtom, P. D., R. A. Larsen, M. E. Leal, and J. M. Leedom. 1992. Prevalence of neurosyphilis in human immunodeficiency virus-infected patients with latent syphilis. Am. J. Med. 93:9-12.
43. Howles, J. K. 1943. A synopsis of clinical syphilis, p. 59-98 and p. 466-499. The C. V. Mosby Co., St. Louis, Mo.
44. Hudson, E. H. 1956. Treponematosis. Current Lit. Vener. Dis., Spec. Issue, p. 56.
45. Hutchinson, C. M., E. W. Hook III, and M. Shepherd. 1994. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann. Intern. Med. 121:94-100.
46. Ingraham, N. R., Jr. 1938. Spirochaeta pallida and the etiology of syphilis, p. 40-46. In Syphilis. Publication 6. American Association for the Advancement of Science, Washington, D.C.
47. Johns, D. R., N. I. Tierney, and D. Felsenstein. 1987. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N. Engl. J. Med. 316:1569-1572.
48. Jorgensen, J., G. Tikjob, and K. Weisman. 1986. Neurosyphilis after treatment of latent syphilis with benzathine penicillin. Genitourin. Med. 62: 129-131.
49. Jorizzo, J. L., M. C. McNeely, R. E. Baughn, A. R. Solomon, T. Cavalls, and E. B. Smith. 1986. Role of circulating immune complexes in human secondary syphilis. J. Infect. Dis. 153:1014-1022.
50. Jozsa, L., M. Timmer, T. Somogyi, and J. Feher. 1977. Hepatitis syphilitica: a clinico-pathological study of 25 cases. Acta Hepatogastroenterol. 24:344-347.
51. Katz, D. A., J. A. Berger, and R. C. Duncan. 1993. Neurosyphilis: a comparative study of the effects of infection with human immunodeficiency virus. Arch. Neurol. 50:243-249.
52. Katz, M. H., S. K. Schwarcz, T. A. Kellogg, et al. 2002. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am. J. Public Health 92:388-394.
53. Kumar, B., and S. Muralidhar. 1998. Malignant syphilis: a review. AIDS Patient Care STDs 12:921-925.
54. Leslie, N. 1964. Treatment of early infectious syphilis with benzathine penicillin G, p. 12-19. In Proc. World Forum Syphilis Other Treponematoses. USPHS publication 997. U.S. Public Health Service, Washington, D.C.
55. Lukehart, S. A., E. W. Hook III, S. A. Baker-Zander, A. C. Collier, C. W. Critchlow, and H. H. Handsfield. 1988. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann. Intern. Med. 109:855-862.
56. Lukehart, S. A., E. W. Hook III, S. A. Baker-Zander, A. C. Collier, C. W. Critchlow, and H. H. Handsfield. 1988. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann. Intern. Med. 109:855-862.
57. Magnuson, H. J., E. W. Thomas, S. Olansky, et al. 1956. Inoculation syphilis in human volunteers. Medicine (Baltimore) 35:33-82.
58. Marra, C. M., P. Boutin, J. C. McArthur, et al. 2000. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin. Infect. Dis. 30:540-544.
59. McCusker, J., A. M. Stoddard, J. G. Zapka, and M. Zorn. 1993. Use of condoms by heterosexually active drug abusers before and after AIDS education. Sex. Transm. Dis. 20:81-88.
60. Misery, L., V. Besnard, R. Badel, E. Marneffe-Delalande, M. Faure, and J. Thiovolet. 1996. Malignant syphilis in human immunodeficiency virus infection. Ann. Dermatol. Venereol. 123:732-734.
61. Morgello, S., and H. Laufer. 1989. Quaternary neurosyphilis. N. Engl. J. Med. 319:1549.
62. Musher, D. M., R. J. Hamill, and R. E. Baughn. 1990. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann. Intern. Med. 113:872-881.
63. Musher, D. M., and J. M. Knox. 1983. Syphilis and yaws, p. 101-120. In R. E. Schell and D. M. Musher (ed.), Pathogenesis and Immunology of treponemal infections. Marcel Dekker, Inc., New York, N.Y.
64. Noguchi, H. 1911. A cutaneous reaction in syphilis. J. Exp. Med. 14:557-561.
65. Norris, S. J., and the T. pallidum Polypeptide Research Group. 1993. Polypeptides of Treponema pallidum: progress toward understanding their structural, functional; and immunological roles. Microbiol. Rev. 57:750-779.
66. Parran, T. 1938. Syphilis: a public health problem, p. 187-193. In Syphilis. Publication 6. American Association for the Advancement of Science, Washington, D.C.
67. Pusey, W. A. 1933. The history and epidemiology of syphilis. Charles C Thomas, Springfield, Ill.
68. Rietmeijer, C. A., J. L. Patnaik, F. N. Judson, and J. M. Douglas. 2003. Increases in gonorrhea and sexual risk behaviors among men who have sex with men: a 12-year trend analysis at the Denver Metro Health Clinic. Sex. Transm. Dis. 30:562-567.
69. Riverius, L. 1946. Of causes of French pox. Urol. Cutan. Rev. 50:510-515.
70. Rolfs, R. T. 1993. Surveillance for primary and secondary syphilis-United States, 1991. Morb. Mortal. Wkly. Rep. 42:13-19.
71. Rolfs, R. T., R. Joesoef, E. F. Hendershot, et al. 1997. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N. Engl. J. Med. 337:307-314.
72. Romero-Jimenez, M. J., L. I. Suarez, P. J. M. Fajardo, and F. B. Baron. 2003. Malignant syphilis in patient with human immunodeficiency virus (HIV); case report and literature review. An. Med. Intern. 20:373-376.
73. Rosebury, T. 1971. Microbes and morals: the strange story of venereal disease. Viking Press, New York, N.Y.
74. Sapra, S., and L. Weatherhead. 1989. Extensive nodular secondary syphilis. Arch. Dermatol. 125:1666-1669.
75. Schaudinn, F., and E. Hoffmann. 1905. Bericht uber das Vorkommen von Spirochaeten in syphilitischen Krankheitsprodukten und bei Papillomen. Arb. Kaiserl. Gesurndheisamte 22:527-532.
76. Schroeter, A. L., J. B. Lucas, E. V. Price, and V. H. Falcone. 1972. Treatment of early syphilis and reactivity of serological tests. JAMA 221:471-496.
77. Shrivastav, S. N., and C. Singh. 1977. Extensive condyloma lata. Br. J. Vener. Dis. 53:23-25.
78. St. Louis, M. E., T. A. Farley, and S. O. Aral. 1996. Untangling the persistence of syphilis in the south. Sex. Transm. Dis. 23:1-4.
79. Tosca A., P. G. Stavropouloos, E. Hatziolou, A. Arvanitis, N. Stavrianeas, M. Hatzivassiliou, and J. D. Stratigos. 1990. Malignant syphilis HIV-infected patients. Int. J. Dermatol. 29:575-578.
80. Tramont, E. C. 1976. Persistence of Treponema pallidum following penicilling G therapy. A report of two cases. JAMA 236:2206-2207.
81. Vonderlehr, R. A. 1942. Impact of war on venereal-disease problems. N. Engl. J. Med. 227:203-205.
82. Witkowski, J. A., and L. C. Parish. 2002. The great imitator: malignant syphilis with hepatitis. Clin. Dermatol. 20:156-163.
83. Yobs, A. R., J. W. Clark, Jr., S. E. Mothershed, J. C. Bullard, and C. W. Artley. 1968. Further observations on the persistence of Treponema pallidum after treatment in rabbits and humans. Br. J. Vener. Dis. 44:116-130.
84. Young, E. J., N. M. Weingarten, R. E. Baughn, and W. C. Duncan. 1982. Studies on the pathogenesis of the Jarisch-Herxheimer reaction: development of an animal model and evidence against a role for classical endotoxin. J. Infect. Dis. 146:606-615.
85. Zaidman, G. W. 1986. Neurosyphilis and retrobulbar neuritis in a patient with AIDS. Ann. Ophthalmol. 18:260-261.
86. Zambrano, W., G. M. Perez, and J. L. Smith. 1987. Acute syphilitic blindness in AIDS. J. Clin. Neurol. Ophthalmol. 7:1-5.